PHG News and Press, Koninklijke Philips N.V. NY Registry Shares From 03/11/22

Royal Philips (NYSE:PHG) said its Collaboration Live received expansion of its U.S. Food & Drug Administration 510(k) market clearance for remote diagnostic use on additional mobile platforms. Available on Philips Ultrasound Systems EPIQ and Affiniti, Collaboration Live allows clinicians ...

March 11, 2022 Industry first integrated, diagnostic quality tele-ultrasound technology lets clinicians talk, text, screen share, and transfer control to remote colleagues in real time New functionality helps increase diagnostic confidence on compatible clients including...

March 10, 2022 Amsterdam, the Netherlands – Royal Philips ’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing recall of certain sleep and respiratory care products in connection w...

Philips partners with basketball legend Grant Hill to celebrate the launch of Philips Norelco OneBlade First Shave The partnership encourages guys on campuses nationwide to post their best bracket-busting facial hair selfies tagging @PhilipsNorelco #NorelcoGroomingChallenge ...

March 10, 2022 Cloud-based Philips HealthSuite Platform, purpose built for health and life sciences, enables connecting data across the care continuum Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, toda...

Solid Q4 beat overshadowed by prudent guidance that removes 4 "imminent" replacement system sales from FY2022 outlook. As per quarterly call, all have physician/administration support and remain “imminent”. Timing of closing the 4 "imminent" replacement sales will determ...

Royal Philips (NYSE:PHG) said a study suggested that its BioTel Heart MCOT patch detected 4.6 times more patients with atrial fibrillation (AF) compared to implantable loop recorder alone. AF is an irregular and rapid heart rhythm that can increase risk of stroke. The company said the study d...

March 9, 2022 As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times lower costs were achieved with improved detection rates a...

ResMed is a great company operationally, with an attractive growth record for sales, profits, and cash flows. Long term, the company will likely continue to do well, with recent growth coming in strong. But shares ultimately look incredibly overpriced even if they are fairly value...

February 22, 2022 1.7 billion lives improved by Philips’ health technology products, services and solutions Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and softwar...